Medicare clozapine data analysis.

<div><p>Schizophrenia-spectrum disorders are debilitating and contribute to a substantial economic burden. Clinicians have historically underutilized clozapine, an atypical antipsychotic traditionally reserved for treatment-resistant schizophrenia, due to the medication’s adverse effect...

全面介紹

Saved in:

書目詳細資料
主要作者:	Luke R. Cavanah (19022435) (author)
其他作者:	Maria Y. Tian (22075705) (author), Jessica L. Goldhirsh (16229023) (author), Leighton Y. Huey (19022438) (author), Brian J. Piper (9870935) (author)
出版:	2025
主題:	Genetics Immunology Cancer Mental Health Environmental Sciences not elsewhere classified underutilization &# 8212 substantial economic burden spending (&# 8722 reduced suicide ideation medication &# 8217 cause mortality benefits associated management requirements adverse effect profile xlink "> schizophrenia pronounced geographic heterogeneity alleviating schizophrenia symptoms historically underutilized clozapine characterize clozapine utilization us medicaid recipients population (&# 8722 poor treatment adherence patterns previously identified 2015 &# 8722 corrected clozapine use clozapine use adjusted pronounced state variation us medicare patients pronounced state medicare patients clozapine use resistant schizophrenia level variation substance use training reform steady decrease spectrum disorders south dakota prescribed significantly practical solutions inadequate training education interventions demonstrated effectiveness 9 %)
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

Medicare clozapine data analysis.

相似書籍